Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Monohydroxyethylrutoside (monoHER), a Novel Antioxidant Agent, Reduces Membrane Oxidative Damage In Vivo in a Mouse Model of B-Thalassemia

Franceschi L, Turrini F, Honczarenko M, Ayi K, Fleming MD, Law T, Gotta S, Kuypers FA, Bast A, van der Vijgh WJF, Brugnara C. . Monohydroxyethylrutoside (monoHER), a Novel Antioxidant Agent, Reduces Membrane Oxidative Damage In Vivo in a Mouse Model of B-Thalassemia. Blood. 2002; 100(11 ):119. Abstract 441.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.